Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nystatin 100,000units/ml oral suspension
0502030B0AAABAB
|
Nystatin (Systemic) | Nystatin | Infections | 168,397 |
|
Diazepam 5mg tablets
0401020K0AAAIAI
|
Diazepam | Diazepam | Central Nervous System | 168,140 |
|
Hydroxychloroquine 200mg tablets
1001030C0AAAAAA
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | 167,948 |
|
AeroChamber Plus
21010230115
|
AeroChamber Plus | Other Appliances | Appliances | 167,586 |
|
GlucoRx lancets 0.31mm/30gauge
21010900689
|
GlucoRx lancets 0.31mm/30gauge | Other Appliances | Appliances | 167,283 |
|
Ketoconazole 2% shampoo
1309000I0AAAAAA
|
Ketoconazole (Scalp) | Ketoconazole | Skin | 167,160 |
|
Medi Derma-S barrier cream
23803068001
|
Medi Derma-S barrier cream | Skin Fillers And Protectives | Stoma Appliances | 166,539 |
|
Estradiol 0.06% gel (750microgram per actuation)
0604011G0AAAUAU
|
Estradiol (Systemic) | Estradiol | Endocrine System | 166,031 |
|
Co-codamol 30mg/500mg capsules
0407010F0AAADAD
|
Co-codamol | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 164,855 |
|
Rigevidon tablets
0703010F0BPAAAC
|
Rigevidon | Combined ethinylestradiol 30mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 163,865 |
|
Irbesartan 300mg tablets
0205052I0AAACAC
|
Irbesartan | Irbesartan | Cardiovascular System | 163,040 |
|
Pregabalin 25mg capsules
0408010AEAAAAAA
|
Pregabalin | Pregabalin | Central Nervous System | 161,667 |
|
GlucoRx Nexus testing strips
0601060D0CUABA0
|
GlucoRx (Reagent) (Blood) | Glucose blood testing reagents | Endocrine System | 161,324 |
|
Venlafaxine 75mg modified-release capsules
0403040W0AAADAD
|
Venlafaxine | Venlafaxine | Central Nervous System | 160,647 |
|
Hydrocortisone 1% / Miconazole 2% cream
1304000V0AACHCH
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 160,461 |
|
Chloramphenicol 0.5% eye drops
1103010C0AAAAAA
|
Chloramphenicol (Eye) | Chloramphenicol | Eye | 159,944 |
|
Salbutamol 100micrograms/dose breath actuated inh CFC free
0301011R0AABUBU
|
Salbutamol | Salbutamol | Respiratory System | 159,037 |
|
Levetiracetam 500mg tablets
0408010A0AAABAB
|
Levetiracetam | Levetiracetam | Central Nervous System | 158,066 |
|
Co-dydramol 10mg/500mg tablets
0407010N0AAAAAA
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 157,795 |
|
Doublebase gel
130201000BBJGCA
|
Proprietary compound emollients | Other emollient preparations | Skin | 157,326 |
|
Atenolol 100mg tablets
0204000E0AAACAC
|
Atenolol | Atenolol | Cardiovascular System | 157,228 |
|
Hyoscine butylbromide 10mg tablets
0102000N0AAABAB
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 156,555 |
|
Pravastatin 10mg tablets
0212000X0AAAAAA
|
Pravastatin sodium | Pravastatin sodium | Cardiovascular System | 156,130 |
|
Monomil XL 60mg tablets
0206010K0CNAAAE
|
Monomil | Isosorbide mononitrate | Cardiovascular System | 155,696 |
|
Olanzapine 10mg tablets
040201060AAACAC
|
Olanzapine | Olanzapine | Central Nervous System | 154,216 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.